Reach Us +44-2476101207
Antibacterial Activity of Crab Shell Extracts Against Human Pathogenic Bacteria and Usage of New Drugs | OMICS International
ISSN: 2329-6631
Journal of Developing Drugs
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Antibacterial Activity of Crab Shell Extracts Against Human Pathogenic Bacteria and Usage of New Drugs

Varadharajan D* and Soundarapandian P

Faculty of Marine Sciences, Centre of Advanced Study in Marine Biology, Annamalai University, Tamil Nadu, India

*Corresponding Author:
Varadharajan D
Faculty of Marine Sciences
Centre of Advanced Study in Marine Biology
Annamalai University, Parangipettai-608 502
Tamil Nadu, India
Tel: 04144-243-223
Fax: 04144-243-553
E-mail: [email protected]

Received Date: July 12, 2013; Accepted Date: August 08, 2013; Published Date: August 16, 2013

Citation: Varadharajan D, Soundarapandian P (2013) Antibacterial Activity of Crab Shell Extracts Against Human Pathogenic Bacteria and Usage of New Drugs. J Develop Drugs 2:110. doi: 10.4172/2329-6631.1000110

Copyright: © 2013 Varadharajan D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Developing Drugs


Fisheries are playing a key role in the changing profile of Indian economic growth. Export of processed and frozen crab products is the backbone of seafood export in India. The industrial processing of crab generates 1,354 tonnes of wastes every year and it largely exists in wastes from the processing of marine food products. The waste generated from the worldwide production and processing of shellfish is a serious problem of growing magnitude and is a threat to the environment. It is essential to convert crab shell waste into useful products such as chitin etc., by recycling and reducing the waste as well as contribute towards gainful employment and economic benefits. The active biomolecules such as chitin and its derivatives are undergoing a significant and very fast development in food application area. Due to recent outbreaks of contaminations associated with food products, there have been growing concerns regarding the negative environmental impact of packaging materials of antimicrobial biofilms. Chitin, since a high antimicrobial activity against a wide variety of pathogenic and spoilage microorganisms. In the present study is aimed at recycling crab shell waste by using it for investigating the antibacterial activity against medically important pathogens.


Scylla serrata; Chitin; Crude extract; Penicillin; Antibacterial activity


Chitin is a long, naturally abundant, non-toxic and biodegradable, polysaccharide and unbranched molecule consisting entirely of N-acetyl-D Glucosamine units linked by β-1,4 bonds. It forms the basis of the shells of arthropods, lobster, shrimp, crab, octopus, nematodes, fungi, squid, jellyfish, green algae and the exoskeletons of insects. The antimicrobial activity is well known and has been exploited in dentistry to prevent caries and as preservative applications in food packaging in several countries [1-4]. The polysaccharide chitin has a documented antibacterial activity varies according to the chemical composition of the chitin. In the present study demonstrates the antibacterial activity of chitin have revealed that chitin is effective in inhibiting growth of bacteria [5]. The antimicrobial properties of chitin depend on its molecular weight and also immune systems from chitin have little potential as bacteriostatic agents [1-3]. In the present study consider about to the drug resistance to human pathogenic bacteria have been commonly reported and the side effects and the resistance that pathogenic microorganisms build against antibiotics. The brachyuran crab, Staphylococcus serrata is a major aquaculture crustacean species and as a result is becoming an increasingly important subject for study, particularly its antimicrobial activities in crude extracts of chitin.

Materials and Methods

The brachyuran crab of Staphylococcus serrata was collected from Parangipettai coast, south east coast of India. After collection the exoskeletons divided into three regions (head, chelated legs & walking legs). They were dried, powdered and stored separately in containers until further use. Deproteinized the exoskeleton by treating with NaOH and boiling at 80-85°C, subsequently washed and dried. The minerals in the sample were dissolved in diluted hydrochloric acid and washed in water. The product obtained after deproteinization and demineralization is called chitin. During deacetylation, N-acetyl group was removed by heating the sample with 40% NaOH for 2-3 hrs at 90°C [6]. Penicillin was used as positive controls while DMSO (dimethyl sulphoxide) disc and sample disc were used as negative controls. A loop full of strain was inoculated with 25 ml of nutrient broth in a conical flask and incubated in a rotary shaker for 17 hrs to activate strain. The assays were performed using the disk diffusion method (Whatman No. 1 filter paper disc, 4.5 mm diameter) [6,7]. The human pathogens like Staphylococcus aureus, S. epidermidis, Bacillus subtilis, Pseudomonas aeruginosa and Pseudomonas mirabilis were used in the study. The antimicrobial activity of these microorganisms was studied against the exoskeleton homogenate crude extract obtained from different parts of the commercial crab.

Results and Discussion

The chitin extracted from Scylla serrata exhibited vital antibacterial activity against the pathogenic bacteria strain Staphylococcus aureus, it was the most effective extract with the maximum zone formation in carapace (10.4 ± 0.12), chelated legs (9.8 ± 0.21), walking legs (8.4 ± 0.15) and positive control formation of zone (10.9 ± 0.25) (Figure 1). The Staphylococcus epidermidis, it was the most effective extract with the maximum zone formation in carapace (9.7 ± 0.19), chelated legs (8.5 ± 0.10), walking legs (7.9 ± 0.25) and positive control zone of inhibition (10.1 ± 0.32) (Figure 2). The pathogenic bacteria strain Bacillus subtilis, it was the ordinary able extract with the maximum zone formation in carapace (9.1 ± 0.31), chelated legs (8.3 ± 0.41), walking legs (7.5 ± 0.34) and positive control formation of zone (9.8 ± 0.35) (Figure 3). The maximum zone formation against the pathogenic bacteria strain Pseudomonas aeruginosa, it was recorded in carapace (7.2 ± 0.15), chelated legs (6.3 ± 0.14), walking legs (5.6 ± 0.23) and positive control zone of inhibition (9.1 ± 0.20) (Figure 4). Similarly, Pseudomonas mirabilis, it was the most effective extract with the maximum zone formation in carapace (6.8 ± 0.26), chelated legs (5.7 ± 0.30), walking legs (5.3 ± 0.24) and positive control formation of zone (8.5 ± 0.28) (Figure 5) [8].


Figure 1: Zone of Inhibition (ZI-mm) in chitin of Staphylococcus serrata against Staphylococcus aureus.


Figure 2: Zone of Inhibition (ZI-mm) in chitin of Staphylococcus serrata against Staphylococcus epidermidis.


Figure 3: Zone of Inhibition (ZI-mm) in chitin of Staphylococcus serrata against Bacillus subtilis.


Figure 4: Zone of Inhibition (ZI-mm) in chitin of Staphylococcus serrata against Pseudomonas aeruginosa.


Figure 5: Zone of Inhibition (ZI-mm) in chitin of Staphylococcus serrata against Pseudomonas mirabilis.

In the present study the results indicated that, the maximum inhibition zone was recorded in gram positive Staphylococcus aureus, S. epidermidis and Bacillus subtilis and the minimum inhibition zone was recorded in gram negative Pseudomonas aeruginosa, Pseudomonas mirabilis, when crab shell extract was used for in vitro screening by disc diffusion method. The microbial associates of marine crustaceans have proven to be a rich source of biologically active substances with antimicrobial, cytotoxic and antineoplastic activities that can be useful for biotechnological and pharmaceutical application. Despite tremendous progress in human medicines today infectious diseases caused by bacteria, viruses, fungi and parasites are still a main threat to public health [9,10]. The impact is particularly large in developing countries due to relative unavailability of medicines and the emergence of widespread drug resistance [11-13]. Antibiotic resistance to manmade drugs is almost not possible to stop because it is the result of some easy rules of evolution. Penicillin, it’s important to understand that antibiotics vary in the way they kill microbes and also specifically attack against bacterial pathogens, still one of the most widely used antibiotics and recently it can be shortage of day by day. In this result showing against pathogenic activity of chitin binding with penicillin, it can solves the shortage problems and also useful for inventing of new drugs. During the last two decades, the development of drug resistance as well as the appearance of undesirable side effects of certain antibiotics has led to the search of new antimicrobial agents mainly among chitin extracts with the goal to discover new chemical structures, which overcome the above disadvantages. Recent research on natural molecule and products primarily focuses on chitin since they can be sourced more easily and be selected based on their ethno medicinal uses. A holistic ecofriently crab shell waste management strategy is outlined for preventing environmental pollution converting crab waste into used as a packaging material for the quality preservation of a variety of food products and its recycling. So searching of chitin which shows antimicrobial properties from crab is the right choice to solve many problems.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 13517
  • [From(publication date):
    October-2013 - Jan 20, 2019]
  • Breakdown by view type
  • HTML page views : 9573
  • PDF downloads : 3944

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2019-20
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

ankara escort

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

pendik escort

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2019 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version